搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
New Atlas
8 小时
Protective protein discovery paves way for healthier aging
New research has revealed that a class of proteins possesses a previously unknown cell-protecting function that could be ...
The Scientist
4 天
Ovarian Proteins That Last a Lifetime Help Maintain Egg Cells for Years
Long-lived proteins in the mouse ovary may help preserve fertility well into adulthood, providing insights into ovarian aging ...
12 天
on MSN
One-step nanoscale expansion microscopy: From molecule to 3D structure with a conventional ...
Germany, have developed a new method that makes it possible for the first time to image the three-dimensional shape of ...
Frontiers
8 天
Biophysical Insights into the Molecular Mechanisms of Neurodegeneration
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (ALS), are characterized by the progressive loss of structure and function of neurons, ...
Outdoor News
1 小时
Legend or reality? Breaking the code of CWD myths
A handful of whitetails in the Illinois deer herd gather for an early November meal in a freshly-shelled field of corn. The ...
labiotech
7 天
Booster launches to treat neurodegenerative diseases with proteasome activation
Discover Booster Therapeutics' novel 20S proteasome activation approach to neurodegenerative diseases as it launches with $15 ...
12 天
Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for ...
Booster Therapeutics launched today with the support of a $15 million financing led by investors Apollo Health Ventures and ...
GlobalData on MSN
10 天
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception, backed by a $15m investment, to develop a new class of proteasome activator ...
5 天
Arvinas: Major Catalyst Ahead, But Its History Gives Me Pause
Despite past performance issues, Arvinas has a solid cash runway. Learn more about ARVN stock's potential and why a cautious ...
GEN
11 天
Booster Therapeutics Secures $15M to Develop Proteasome Activators for Treating Complex ...
The company is developing molecules that boost the ubiquitin-independent protein degradation activity of 20S proteasomes in ...
12 天
Global Proteolysis Targeting Chimeras PROTAC Targeted Protein Degradation Therapy Clinical ...
Currently There Are More Than 50 PROTAC Drugs In Clinical Trials And Majority Are For Cancer As Per Recent Study By Kuick ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈